CASTLE BIOSCIENCES, INC. Debt Securities Available For Sale And Held To Maturity Cumulative Unrecognized Gain
CASTLE BIOSCIENCES, INC. (CSTL) had Debt Securities Available For Sale And Held To Maturity Cumulative Unrecognized Gain of $151.00 thousand as of 2025-03-31, per its 10-Q filed 2025-05-05.
Financial Statements › Notes › Debt and Equity Securities › Debt Securities, Available-for-Sale and Held-to-Maturity, Fair Value to Amortized Cost, after Allowance for Credit Loss
us-gaap:DebtSecuritiesAvailableForSaleAndHeldToMaturityCumulativeUnrecognizedGain · last filed 2025-05-05
- 2025-03-31: Debt Securities Available For Sale And Held To Maturity Cumulative Unrecognized Gain $151.00K.
- 2024-12-31: Debt Securities Available For Sale And Held To Maturity Cumulative Unrecognized Gain $244.00K.
| Period end | Debt Securities Available For Sale And Held To Maturity Cumulative Unrecognized Gain |
|---|---|
| 2025-03-31 | $151.00K 10-Q · filed 2025-05-05 |
| 2024-12-31 | $244.00K 10-Q · filed 2025-05-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B |